Literature DB >> 31219653

CRISPR-Cas system: Toward a more efficient technology for genome editing and beyond.

Vahideh Ahmadzadeh1, Safar Farajnia1,2, Roghayyeh Baghban2, Leila Rahbarnia3, Habib Zarredar4.   

Abstract

Genome engineering technology is of great interest for biomedical research that enables scientists to make specific manipulation in the DNA sequence. Early methods for introducing double-stranded DNA breaks relies on protein-based systems. These platforms have enabled fascinating advances, but all are costly and time-consuming to engineer, preventing these from gaining high-throughput applications. The CRISPR-Cas9 system, co-opted from bacteria, has generated considerable excitement in gene targeting. In this review, we describe gene targeting techniques with an emphasis on recent strategies to improve the specificities of CRISPR-Cas systems for nuclease and non-nuclease applications.
© 2019 Wiley Periodicals, Inc.

Keywords:  Application; CRISPR-Cas9 system; Efficiency; Genome editing

Year:  2019        PMID: 31219653     DOI: 10.1002/jcb.29140

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Terminalia Catappa Extract (TCE) Reduces Proliferation of Lung and Breast Cancer Cell by Modulating miR-21 and miR-34a Expressions.

Authors:  Habib Zarredar; Amir Mahdi Khamaneh; Fatemeh Firouzi Amoodizaj; Dariush Shanaehbandi; Ensiyeh Seyedrezazadeh; Hamed Sabagh Jadid; Milad Asadi; Venus Zafari; Yeganeh Khalili; Zahra Soleimani; Atefeh Ansarin; Majid Khalili
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

Review 2.  Application of the CRISPR/Cas9 System to Study Regulation Pathways of the Cellular Immune Response to Influenza Virus.

Authors:  Daria Prokhorova; Natalya Zhukova Eschenko; Anna Lemza; Mariia Sergeeva; Rinat Amirkhanov; Grigory Stepanov
Journal:  Viruses       Date:  2022-02-21       Impact factor: 5.048

3.  Combination Therapy with KRAS and P38α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line.

Authors:  Shiva Kamran; Ensiyeh Seyedrezazadeh; Dariush Shanehbandi; Milad Asadi; Venus Zafari; Najibeh Shekari; Leila Namvar; Habib Zarredar
Journal:  J Gastrointest Cancer       Date:  2021-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.